Leana Wen - Sep 8, 2022 Form 3 Insider Report for UroGen Pharma Ltd. (URGN)

Role
Director
Signature
/s/ Jason Smith, Attorney-in-Fact
Stock symbol
URGN
Transactions as of
Sep 8, 2022
Transactions value $
$0
Form type
3
Date filed
9/12/2022, 08:29 AM
Previous filing
Jun 6, 2022
Next filing
Jan 4, 2023

No securities are beneficially owned.